1 |
Klitenick, M.A., DeWitte, P., and Kalivas, P.W. (1992) Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12, 2623-2632
|
2 |
van der Kooy, D. (1987) Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In Methods of Assessing the Reinforcing Properties of Abuse Drugs (M.A. Bozarth, Ed.), pp. 229-240. Springer, New York
|
3 |
Deisseroth, K, Bito, H, and Tsien, R.W. (1996) Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 16, 89-101
DOI
ScienceOn
|
4 |
Fan, G.H., Wang, L.Z., Qiu, H.C., Ma, L., and Pei, G. (1999) Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 56, 39-45
DOI
|
5 |
Gao, C., Che, L.W., Chen, J., Xu, X.J., and Chi, Z.Q. (2003) Ohmefentanyl stereoisomers induce changes of CREB phosphorylation in hippocampus of mice in conditioned place preference paradigm. Cell Res. 13, 29-34
DOI
ScienceOn
|
6 |
Graybiel, A.M., Moratalla, R., and Robertson, H.A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87, 6912-6916
DOI
ScienceOn
|
7 |
Lee, M.K. and Zhang, Y.H. (1996) Inhibition of tyrosine hydroxylase by berberine. Med. Sci. Res. 24, 561-562
|
8 |
Kim, H.S., Jang, C.G., and Park, W.K. (1996) Inhibition by MK- 801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 55, 11-17
DOI
ScienceOn
|
9 |
Koob, G.F. and Bloom, F.E. (1988) Cellular and molecular mechanisms of drug dependence. Science 242, 715-723
DOI
|
10 |
Lee, M.K. and Kim, H.S. (1996) Inhibitory effects of protoberberine alkaloids from the roots of Coptis japonica on catecholamine biosynthesis in PC12 cells. Planta Med. 62, 31-34
DOI
ScienceOn
|
11 |
Lee, M.K., Zhang, Y.H., and Kim, H.S. (1996) Inhibition of tyrosine hydroxylase by palmatine. Arch. Pharm. Res. 19, 258-260
DOI
|
12 |
Bardo, M.T., Miller, J.S., and Neisewander, J.S. (1984) Conditioned place preference with morphine: The effect of extinction training on the reinforcing CR. Pharmacol. Biochem. Behav. 21, 545-549
DOI
ScienceOn
|
13 |
Berke, J.D. and Hyman, S.E. (2000) Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25, 515-532
DOI
ScienceOn
|
14 |
Bozarth, M.A. (1986) Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system. Behav. Brain Res. 22, 107- 116
DOI
ScienceOn
|
15 |
Hsieh, M.T., Peng, W.H., Wu, C.R., and Wang, W.H. (2000) The ameliorating effects of the cognitive-enhancing Chinese herbs on scopolamine-induced amnesia in rats. Phytotherapy Res. 14, 375-377
DOI
ScienceOn
|
16 |
Lee, S.Y, Song, D.K, and Jang, C.G. (2003) Effects of Coptis japonica on morphine-induced conditioned place preference in mice. Arch Pharm Res. 26, 540-544
DOI
ScienceOn
|
17 |
Hyman, S.E. (1996) Shaking out the cause of addiction. Science 273, 611-612
DOI
ScienceOn
|
18 |
Ivanovska, N. and Philipov, S. (1996) Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int. J. Immunopharmacol. 18, 553- 561
DOI
ScienceOn
|
19 |
Johnson, S.W. and North, R.A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488
|
20 |
Lou, L.G., Zhou, T.H., Wang, P., and Pei, G. (1999) Modulation of /Calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of a and b isoforms. Mol. Pharmacol. 55, 557-563
|
21 |
Mucha, R.F., van der Kooy, D., O'Shaughnessy, M., and Bucenieks, P. (1982) Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243, 91-105
DOI
ScienceOn
|
22 |
Nestler, E.J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128
DOI
ScienceOn
|
23 |
Ro, J.S., Lee, S.S., Lee, K.S., and Lee, M.K. (2001) Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci. 70, 639-645
DOI
ScienceOn
|
24 |
Robbins, T.W. and Everiff, B.J. (1999) Drug addiction: bad habits add up. Nature 398, 567-570
DOI
ScienceOn
|
25 |
Wise, R.A. and Rompre, P.P. (1989) Brain dopamine and reward. Ann. Rev. Psychol. 40, 191-225
DOI
ScienceOn
|
26 |
Schmeller, T., Latz-Bruning, B., and Wink, M. (1997) Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defense against microorganisms and herbivores. Phytochemistry 44, 257-266
DOI
ScienceOn
|
27 |
Shin, J.S., Kim, E.I., Kai, M., and Lee, M.K. (2000) Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25, 363-368
DOI
ScienceOn
|
28 |
Tolliver, B.K., Sganga, M.W., and Sharp, F.R. (2000) Suppression of c-fos induction in the nucleus accumbens prevents acquisition but not expression of morphine-conditioned place preference. Eur. J. Neurosci. 12, 3399-3406
|
29 |
Wise, R.A. and Bozarth, M.A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492
DOI
ScienceOn
|
30 |
Yoo, J.H., Yang, E.M., Cho, J.H., Lee, J.H., Jeong, S.M., Nah, S.Y., Kim, H.C., Kim, K.W., Kim, S.H., Lee, S.Y., and Jang, C.G., (2006) Inhibitory effects of berberine against morphineinduced locomotor sensitization and analgesic tolerance in mice. Neuroscience 142, 953-961
DOI
ScienceOn
|
31 |
Young, S.T., Porrino, L.J., and Iadarola, M.J. (1991) Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA 88, 1291-1295
DOI
ScienceOn
|
32 |
Baker, H. and Farbman, A.I. (1993) Olfactory afferent regulation of the dopamine phenotype in the fetal rat olfactory system. Neuroscience 52, 115-134
DOI
ScienceOn
|
33 |
Shuster, L., Hannam, R.V., and Boyle, W.E.Jr. (1963) A simple method for producing tolerance to dihydromorphine in mice. J. Pharmacol. Exp. Ther. 140, 149-153
|